Cargando…

Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil

BACKGROUND: Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar, Anna Caroline C, Pereira, Dhelio B, Amaral, Nayra S, De Marco, Luiz, Krettli, Antoniana U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945814/
https://www.ncbi.nlm.nih.gov/pubmed/24581308
http://dx.doi.org/10.1186/1475-2875-13-73
_version_ 1782306580181549056
author Aguiar, Anna Caroline C
Pereira, Dhelio B
Amaral, Nayra S
De Marco, Luiz
Krettli, Antoniana U
author_facet Aguiar, Anna Caroline C
Pereira, Dhelio B
Amaral, Nayra S
De Marco, Luiz
Krettli, Antoniana U
author_sort Aguiar, Anna Caroline C
collection PubMed
description BACKGROUND: Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite reported resistance, is treated with CQ as well as with primaquine to block malaria transmission and avoid late P. vivax malaria relapses. Resistance to CQ and other antimalarial drugs influences malaria control, thus monitoring resistance phenotype by parasite genotyping is helpful in endemic areas. METHODS: A total of 47 P. vivax and nine P. falciparum fresh isolates were genetically characterized and tested for CQ, mefloquine (MQ) and artesunate (ART) susceptibility in vitro. The genes mdr1 and pfcrt, likely related to CQ resistance, were analyzed in all isolates. Drug susceptibility was determined using short-term parasite cultures of ring stages for 48 to 72 hour and thick blood smears counts. Each parasite isolate was tested with the antimalarials to measure the geometric mean of 50% inhibitory concentration. RESULTS: The low numbers of P. falciparum isolates reflect the species prevalence in Brazil; most displayed low sensitivity to CQ (IC50 70 nM). However, CQ resistance was rare among P. vivax isolates (IC(50) of 32 nM). The majority of P. vivax and P. falciparum isolates were sensitive to ART and MQ. One hundred percent of P. falciparum isolates carried non-synonymous mutations in the pfmdr1 gene in codons 184, 1042 and 1246, 84% in codons 1034 and none in codon 86, a well-known resistance mutation. For the pfcrt gene, mutations were observed in codons 72 and 76 in all P. falciparum isolates. One P. falciparum isolate from Angola, Africa, showing sensitivity to the antimalarials, presented no mutations. In P. vivax, mutations of pvmdr1 and the multidrug resistance gene 1 marker at codon F976 were absent. CONCLUSION: All P. falciparum Brazilian isolates showed CQ resistance and presented non-synonymous mutations in pfmdr1 and pfcrt. CQ resistant genotypes were not present among P. vivax isolates and the IC(50) values were low in all samples of the Brazilian West Amazon.
format Online
Article
Text
id pubmed-3945814
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39458142014-03-08 Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil Aguiar, Anna Caroline C Pereira, Dhelio B Amaral, Nayra S De Marco, Luiz Krettli, Antoniana U Malar J Research BACKGROUND: Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite reported resistance, is treated with CQ as well as with primaquine to block malaria transmission and avoid late P. vivax malaria relapses. Resistance to CQ and other antimalarial drugs influences malaria control, thus monitoring resistance phenotype by parasite genotyping is helpful in endemic areas. METHODS: A total of 47 P. vivax and nine P. falciparum fresh isolates were genetically characterized and tested for CQ, mefloquine (MQ) and artesunate (ART) susceptibility in vitro. The genes mdr1 and pfcrt, likely related to CQ resistance, were analyzed in all isolates. Drug susceptibility was determined using short-term parasite cultures of ring stages for 48 to 72 hour and thick blood smears counts. Each parasite isolate was tested with the antimalarials to measure the geometric mean of 50% inhibitory concentration. RESULTS: The low numbers of P. falciparum isolates reflect the species prevalence in Brazil; most displayed low sensitivity to CQ (IC50 70 nM). However, CQ resistance was rare among P. vivax isolates (IC(50) of 32 nM). The majority of P. vivax and P. falciparum isolates were sensitive to ART and MQ. One hundred percent of P. falciparum isolates carried non-synonymous mutations in the pfmdr1 gene in codons 184, 1042 and 1246, 84% in codons 1034 and none in codon 86, a well-known resistance mutation. For the pfcrt gene, mutations were observed in codons 72 and 76 in all P. falciparum isolates. One P. falciparum isolate from Angola, Africa, showing sensitivity to the antimalarials, presented no mutations. In P. vivax, mutations of pvmdr1 and the multidrug resistance gene 1 marker at codon F976 were absent. CONCLUSION: All P. falciparum Brazilian isolates showed CQ resistance and presented non-synonymous mutations in pfmdr1 and pfcrt. CQ resistant genotypes were not present among P. vivax isolates and the IC(50) values were low in all samples of the Brazilian West Amazon. BioMed Central 2014-02-28 /pmc/articles/PMC3945814/ /pubmed/24581308 http://dx.doi.org/10.1186/1475-2875-13-73 Text en Copyright © 2014 Aguiar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Aguiar, Anna Caroline C
Pereira, Dhelio B
Amaral, Nayra S
De Marco, Luiz
Krettli, Antoniana U
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title_full Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title_fullStr Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title_full_unstemmed Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title_short Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil
title_sort plasmodium vivax and plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in rondônia, west amazon, brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945814/
https://www.ncbi.nlm.nih.gov/pubmed/24581308
http://dx.doi.org/10.1186/1475-2875-13-73
work_keys_str_mv AT aguiarannacarolinec plasmodiumvivaxandplasmodiumfalciparumexvivosusceptibilitytoantimalarialsandgenecharacterizationinrondoniawestamazonbrazil
AT pereiradheliob plasmodiumvivaxandplasmodiumfalciparumexvivosusceptibilitytoantimalarialsandgenecharacterizationinrondoniawestamazonbrazil
AT amaralnayras plasmodiumvivaxandplasmodiumfalciparumexvivosusceptibilitytoantimalarialsandgenecharacterizationinrondoniawestamazonbrazil
AT demarcoluiz plasmodiumvivaxandplasmodiumfalciparumexvivosusceptibilitytoantimalarialsandgenecharacterizationinrondoniawestamazonbrazil
AT krettliantonianau plasmodiumvivaxandplasmodiumfalciparumexvivosusceptibilitytoantimalarialsandgenecharacterizationinrondoniawestamazonbrazil